Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction.
Mesh Terms:
Angiotensin-Converting Enzyme 2, COVID-19, Ceftazidime, Cell Line, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Angiotensin-Converting Enzyme 2, COVID-19, Ceftazidime, Cell Line, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Signal Transduct Target Ther
Date: Dec. 18, 2020
PubMed ID: 34006835
View in: Pubmed Google Scholar
Download Curated Data For This Publication
223770
Switch View:
- Interactions 1